Filter Results :

Your search for Lymphoma returned 125 reports

Sort by


Burkitt Lymphoma - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Burkitt Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Burkitt Lymphoma’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkitt Lymphoma, complete with comparative analysis at various stages, therapeutics assessment ...

$ 2,000.00

Read More

The 2016-2021 World Outlook for Lymphoma Therapeutics

01 Apr 2015  |  Published by:  Icon Group International, Inc
This econometric study covers the world outlook for Lymphoma therapeutics across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the count...

$ 995.00

Read More

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anaplastic Lymphoma Kinase (ALK) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Lymphoma Kinase (ALK) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technolo...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Cutaneous T-Cell Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cutaneous T-Cell Lymphoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and...

$ 1,250.00

Read More

Burkitt Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Burkitt Lymphoma-API Insights, 2015,report provides Burkitt Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

The 2016 Report on Lymphoma Therapeutics: World Market Segmentation by City

01 Apr 2015  |  Published by:  Icon Group International, Inc
This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report cov...

$ 995.00

Read More

Non-Hodgkin Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Non-Hodgkin Lymphoma-API Insights, 2015,report provides Non-Hodgkin Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More

T-Cell Lymphomas-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary T-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the T-Cell Lymphomas. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing dea...

$ 1,250.00

Read More

B-Cell Lymphomas-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary B-Cell Lymphomas- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the B-Cell Lymphomas. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing dea...

$ 1,250.00

Read More

Anaplastic Large Cell Lymphoma (ALCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Anaplastic Large Cell Lymphoma (ALCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anaplastic Large Cell Lymphoma (ALCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collabor...

$ 1,250.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, T-Cell Lymphomas-API Insights, 2015,report provides T-Cell Lymphomas drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide c...

$ 1,250.00

Read More

B-Cell Non-Hodgkin Lymphoma-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary B-Cell Non-Hodgkin Lymphoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the B-Cell Non-Hodgkin Lymphoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

$ 1,250.00

Read More

Lymphoblastic Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Lymphoblastic Lymphoma-API Insights, 2015,report provides Lymphoblastic Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2015

01 Apr 2015  |  Published by:  DelveInsight
Summary Peripheral T-Cell Lymphomas (PTCL)- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peripheral T-Cell Lymphomas (PTCL). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations...

$ 1,250.00

Read More

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

01 Apr 2015  |  Published by:  DelveInsight
SummaryDelveInsight’s, Mantle Cell Lymphoma-API Insights, 2015,report provides Mantle Cell Lymphoma drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by wor...

$ 1,250.00

Read More
Total 125 records.